DiaMedica Therapeutics (DMAC) Inventory Average (2023)

DiaMedica Therapeutics' (DMAC) quarterly Inventory Average came in at $516000.0 in Q4 2023, up 33.33% quarter-over-quarter from $387000.0 in Q3 2023.

DiaMedica Therapeutics (DMAC) Inventory Average (2023) Analysis & Trends

DiaMedica Therapeutics' Inventory Average history runs 1 years deep, the most recent figure standing at $516000.0 for Q4 2023.

On a quarterly basis, Inventory Average changed N/A year-over-year to $516000.0 in Q4 2023; TTM through Dec 2023 was $516000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $179500.0, up 131.61% from the prior year.
Inventory Average climbed to $516000.0 in Q4 2023 per DMAC's latest filing, from $387000.0 in the prior quarter.
Across five years, Inventory Average topped out at $516000.0 in Q4 2023 and bottomed at $67000.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	644.91 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.73 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.15 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	DiaMedica Therapeutics	366.87 Mn	366.87 Mn	-	-

Download Data